Debut Plus

0.5

+0 +0.00%

As of 10 Sept 2026 · delayed

BSE Listed

Shree Ganesh Biotech India Ltd. (539470)

Volume: 3,89,150Avg Vol 1W: 7,48,805Avg Vol 1M: 7,15,14652W Range:0.480.8
Key Ratios
Checked 5h ago
Market Cap₹20 Cr
Current Price₹0.5
Previous Close₹0.5
High / Low (52w)₹0.8 / ₹0.48
Volume3,89,150
Avg Vol (1W)7,48,805
Avg Vol (1M)7,15,146
Stock P/E55
Book Value₹1.6
Dividend Yield0%
ROE59.34%
ROA-61.13%
Revenue (TTM)
Revenue Growth
Profit Margin-7.77%
Total Debt
Shares Outstanding40 Cr
Face Value
EPS (TTM)₹0
P/B0.31
Debt / Equity0
50 DMA₹0.53
200 DMA₹0.6
Day change+0.00%
Price Chart
0.5 36.71% · 1Y
1029.7L
2025-09-10
2026-09-10

20-day avg volume: 6.8L shares

Pros
  • Healthy return on equity of 59.3%.
  • Company is almost debt-free.
  • Net profit is growing year over year.
  • Stock trades below its book value.
Cons
  • Revenue fell 74% YoY.
  • Stock trades at a high P/E of 55.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹2 Cr₹14 Cr₹3 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr
EBITDA₹0 Cr₹1 Cr₹-1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr
Net Profit₹0 Cr₹1 Cr₹-1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr
EPS
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹6 Cr₹2 Cr₹17 Cr₹73 Cr₹63 Cr₹21 Cr₹24 Cr₹6 Cr
EBITDA₹2 Cr₹0 Cr₹1 Cr₹3 Cr₹3 Cr₹1 Cr₹0 Cr₹1 Cr
Net Profit₹2 Cr₹0 Cr₹0 Cr₹3 Cr₹2 Cr₹1 Cr₹0 Cr₹0 Cr
EPS0.90.120.020.130.050.020.010.01
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹64 Cr₹65 Cr₹75 Cr₹94 Cr₹80 Cr₹74 Cr₹63 Cr₹64 Cr
Total Liabilities₹7 Cr₹7 Cr₹17 Cr₹33 Cr₹17 Cr₹11 Cr₹0 Cr₹0 Cr
Equity₹57 Cr₹57 Cr₹58 Cr₹60 Cr₹62 Cr₹63 Cr₹63 Cr₹64 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹2 Cr₹5 Cr₹11 Cr₹10 Cr₹-10 Cr₹-8 Cr
Investing₹-2 Cr₹-3 Cr₹-10 Cr₹-10 Cr₹10 Cr₹8 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Free Cash Flow₹2 Cr₹5 Cr₹11 Cr₹10 Cr₹-10 Cr₹-8 Cr
Shareholding
Promoter 0% Institutions 1.42% Public 98.58%
Efficiency & Working Capital
ROCE0.8%
Interest Coverage0
Dividend Payout
Debtor Days0 d
Inventory Days861 d
Payable Days0 d
Cash Conversion Cycle861 d
Working Capital Days861 d
Shareholding Details

As of 2026-06-30

Promoter0%
FII1.4%
DII0%
Institutions1.4%
Public98.6%
Promoter Pledge
No. of Shareholders1,81,722
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters0%0%0%0%0%0%0%0%0%0%0%0%
FIIs2.2%2.2%1.4%1.4%1.4%1.4%1.4%1.4%1.4%1.4%1.4%1.4%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public97.8%97.8%98.6%98.6%98.6%98.6%98.6%98.6%98.6%98.6%98.6%98.6%
Promoter Pledge
No. of Shareholders78,0961,39,8801,76,7221,81,1981,85,3351,92,0401,95,4351,92,2351,89,3751,86,1481,83,6581,81,722
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
New Era Fund LimitedPublic Shareholding1.4%56,64,940
Board of Directors
NameDesignationYear
Aman PatelChairman / Executive Director / WTD2025
Kishan Nityanand NaiduExecutive Director & CFO2025
SOMBIR SINGHIndependent Non Exe. Director2025
Amrutaben SolankiIndependent Non Exe. Director2025
Nimeshkumar ParmarIndependent Non Exe. Director2025
Harshadkumar RathodIndependent Non Exe. Director2025
Namita AcharyaCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1404040
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-04Board Meetings
Substantial Acquisitions (SAST)

5 disclosure(s)

Market25/09/2023 - 17/10/2023 · 1,99,00,000
Market12/09/2023 - 16/10/2023 · 2,61,00,000
Off Market11/09/2023 - 13/09/2023 · 3,23,00,000
Market08/09/2023 · 1,95,00,000
Market06/09/2023 · 1,95,50,000
Company Information
Incorporated1982
ChairmanAman Patel
AuditorBipin & co
Investor Email[email protected]
🌐 www.shreeganeshbiotech.com

📍 6 Flr Premises-602 Mahavir Apt, 2 Aushutosh Mukherjee Road, Kolkata, West Bengal, 700020

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search